These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37140894)

  • 1. Predictive Impact of Prognostic Nutritional Index in Patients with Cancer Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
    Xu XT; Qian Y; Tian MX; Ding CC; Guo H; Tang J; Pi GL; Wu Y; Dai Z; Jin X
    Nutr Cancer; 2023; 75(6):1413-1426. PubMed ID: 37140894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of prognostic nutritional indices in gastric or gastro-esophageal junction cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
    Hou S; Song D; Hao R; Li L; Zhang Y; Zhu J
    Front Immunol; 2024; 15():1382417. PubMed ID: 38966640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of prognostic nutritional index in advanced cancer receiving PD-1/L1 inhibitors: A meta-analysis.
    Li P; Lai Y; Tian L; Zhou Q
    Cancer Med; 2022 Aug; 11(16):3048-3056. PubMed ID: 35297197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors.
    Zhang L; Ma W; Qiu Z; Kuang T; Wang K; Hu B; Wang W
    Front Immunol; 2023; 14():1219929. PubMed ID: 37545502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region.
    Wu Y; Yang J; Qiao X; Li Y; Zhao R; Lin T; Li X; Wang M
    Front Oncol; 2023; 13():1041140. PubMed ID: 37007079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Nutritional Index Predicts Response and Prognosis in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
    Ni L; Huang J; Ding J; Kou J; Shao T; Li J; Gao L; Zheng W; Wu Z
    Front Nutr; 2022; 9():823087. PubMed ID: 35938131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
    Xia H; Zhang W; Zheng Q; Zhang Y; Mu X; Wei C; Wang X; Liu Y
    Heliyon; 2023 Aug; 9(8):e17400. PubMed ID: 37520982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment "prognostic nutritional index" as an indicator of outcome in lung cancer patients receiving ICI-based treatment: Systematic review and meta-analysis.
    Shao Y; Cao W; Gao X; Tang M; Zhu D; Liu W
    Medicine (Baltimore); 2022 Oct; 101(43):e31113. PubMed ID: 36316884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional status as prognostic factor of advanced oesophageal cancer patients treated with immune checkpoint inhibitors.
    Chen N; Yu Y; Shen W; Xu X; Fan Y
    Clin Nutr; 2024 Jan; 43(1):142-153. PubMed ID: 38043419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of neutrophil to lymphocyte ratio in gastric cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
    Zhang S; Qiu C; Yu H; Xu Y; Xu X
    Front Oncol; 2023; 13():1070019. PubMed ID: 37143942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint inhibitors plus chemotherapy versus chemotherapy alone as first-line therapy for advanced gastric and esophageal cancers: A systematic review and meta-analysis.
    Noori M; Mahjoubfar A; Azizi S; Fayyaz F; Rezaei N
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109317. PubMed ID: 36252494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors.
    Sun H; Chen L; Huang R; Pan H; Zuo Y; Zhao R; Xue Y; Song H
    Front Nutr; 2022; 9():1038118. PubMed ID: 36438745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Impact of Sarcopenia on Clinical Outcomes in Malignancies Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
    Li S; Wang T; Tong G; Li X; You D; Cong M
    Front Oncol; 2021; 11():726257. PubMed ID: 34513704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors.
    Yan X; Wang J; Mao J; Wang Y; Wang X; Yang M; Qiao H
    Front Nutr; 2023; 10():1213255. PubMed ID: 37575320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic effect of the pretreatment prognostic nutritional index in cervical, ovarian, and endometrial cancer: a meta-analysis.
    Li C; Yin Y; Yang Z; Zhang Q; Wang W; Liu J
    BMC Womens Health; 2024 Aug; 24(1):464. PubMed ID: 39180039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of nutritional indices in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
    Miyamoto N; Takenaka Y; Sudo T; Eguchi H; Tanaka H; Fukusumi T; Takemoto N; Suzuki M; Inohara H
    Acta Otolaryngol; 2023 Oct; 143(10):925-930. PubMed ID: 38059478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients.
    Tu X; Ren J; Zhao Y
    Oral Oncol; 2020 Nov; 110():104991. PubMed ID: 32919361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to Choose a Survival Period? The Impact of Antibiotic Use on OS or PFS in NSCLC Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
    Chen H; Han KD; He ZJ; Huang YS
    Technol Cancer Res Treat; 2021; 20():15330338211033498. PubMed ID: 34323149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Efficacy of Blood-Based Tumor Mutation Burden Assay for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Zhang N; Zhang J; Wang G; He X; Mi Y; Cao Y; Yu X
    Front Oncol; 2022; 12():795933. PubMed ID: 35223476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Significance of Transarterial Chemo(Embolization) Combined With Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review.
    Ke Q; Xin F; Fang H; Zeng Y; Wang L; Liu J
    Front Immunol; 2022; 13():913464. PubMed ID: 35677059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.